摘要
胶质母细胞瘤(glioblastoma,GBM)是最常见的颅内原发恶性肿瘤,2006-2010年美国新诊断的颅内恶性肿瘤中GBM约占45.2%。GBM具有高复发率、高死亡率的特点,中位生存期仅14-16个月,中位复发时间为6.2个月,复发后的中位生存期仅为25-30周。
出处
《临床神经外科杂志》
CAS
2016年第5期394-397,共4页
Journal of Clinical Neurosurgery
参考文献28
-
1Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010[ J]. Neuro Oncol,2013,15:1.
-
2Van Meir EG, Hadjipanayis CG, Norden AD, et al. Exciting new advances in neuro-oneology: the avenue to a cure for malignant glioma[ J ]. CA Cancer J Clin,2010 ,60 :166.
-
3Kostron H, Bauer R. Management of recurrent malignant glioma-neurosurgical strategies [ J ]. Wien Med Wochenschr,2011,161:20.
-
4梁晨,郭世文.荧光引导切除术治疗胶质瘤的临床研究及进展[J].临床神经外科杂志,2012,9(4):250-252. 被引量:4
-
5Clarke JL, Ennis MM, Lamborn KR, et al. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? [ J ]. Neuro Onco1,2010 ,12 :69.
-
6Mandl ES, Dirven C, Buis DR,et al. Repeated surgery for glioblas- toma muhiforme: only in combination with other salvage therapy [ J]. Surg Neurol,2008,69:506.
-
7Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article [ J ]. J Neurosurg,2012,117 : 1032.
-
8Park CK,Kim JH, Nam DH,et al. A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma[ J]. Neuro Onco1,2013,15 : 1096.
-
9汪洋,盛晓芳,董伟,高伟,倪春霞,戴嘉中,孙磊,潘力.19例复发性高分级胶质瘤再程放疗的经验[J].中国肿瘤临床,2011,38(20):1271-1274. 被引量:3
-
10Torok JA, Wegner RE, Mintz AH,et al. Re-irradiation withradiosur- gery for recurrent glioblastoma multiforme[ J]. Technol Cancer Res Treat,2011,10:253.
二级参考文献15
-
1Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial[J]. Lancet Oncol, 2009, 10(5): 459-466.
-
2Mayer R, Sminia P. Reirradiation tolerance of the human brain[J]. IntJ Radiat Oncol Biol Phys, 2008, 70(5): 1350-1360.
-
3Nieder C, Grosu AL, Anderatschke NH, et al. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients[J]. IntJ Radiat Oncol Biol Phys, 2005, 61(3): 851-855.
-
4Hopewell JW, Millar WT, Ang KK. Toward improving the therapeutic ratio in stereotactic radiosurgery: selective modulation of the radiation responses of both normal tissues and mmor[J]. J Neurosurg, 2007, 107(1): 84-93.
-
5Nieder C, Nestle U, Niewald M, et al. Hyperfractionated reirradiation for malignant glioma[J]. Front Radiat Ther Oncol, 1999, 33: 150-157.
-
6Nieder C, Grosu AL, Moll M. A comparison of treatment results for recurrent malignant gliomas[J]. Cancer Treat Rev, 2000, 26(6): 397-409.
-
7Veninga T, Langendijk HA, Slotman BJ, et al. Reirradiation of primary brain tumors: survival, clinical response and prognostic factors[J]. Radiother Oncol, 2001, 59(2): 127-137.
-
8Eenst-Stecken A, Ganslandt O, Lambrecht L, et al. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma[J].J Neurooncol, 2007, 81 (3): 287-294.
-
9Hudes RS, Corn BW, Werner-Wasik M, et al. A phase I dose escalation study of hypofractionated stereotacdc radiotherapy as salvage therapy for persistent of recurrent malignant glioma[J]. Int J Radiat Oncol Biol Phys, 1999, 43(2): 293-298.
-
10Nieder C, Adam M, Moll M, et al. Therapeutic option for recurrent high-grade glioma in adult patients: recent advances[J]. Crit Rev Oncol Hematol, 2006, 60(3): 181-193.
共引文献5
-
1高伟,汪洋,盛晓芳,倪春霞.再程放疗联合尼妥珠单抗治疗复发性高分级胶质瘤的初步研究[J].肿瘤,2012,32(7):551-554. 被引量:3
-
2农大件,李国成,周围.神经胶质瘤的治疗研究进展[J].中国医药指南,2013,11(26):58-60. 被引量:9
-
3王雪华.中医辨证联合西药治疗脑胶质瘤研究进展[J].辽宁中医药大学学报,2015,17(9):216-218. 被引量:8
-
4丁建明,江浩,汪庚明.复发胶质瘤的影像诊断与放射治疗[J].现代临床医学,2018,44(3):165-168. 被引量:1
-
5高峰,麦麦提依明·托合提,张诚,孙连杰,帕热哈提江·依孜木,董军,吴永刚,杨小朋.荧光素钠辅助引导技术在脑恶性肿瘤扩大切除手术中的临床分析[J].临床神经外科杂志,2022,19(6):668-671.
同被引文献8
-
1吕晓皑,王蓓,陈建彬,叶荆.miR-363对顺铂耐药乳腺癌细胞的作用及机制[J].中国现代应用药学,2015,32(9):1041-1046. 被引量:6
-
2徐峰,章蔚,田景琦.miR-363通过靶向于MCL-1增强顺铂对乳腺癌细胞的杀伤活性[J].中国卫生检验杂志,2015,25(19):3236-3239. 被引量:1
-
3张庆勇,朱武飞,付晶.非编码长链RNA作为肿瘤标志物的研究进展[J].中国肿瘤,2016,25(12):984-987. 被引量:7
-
4李芳卉,李东泽,张蜀,赵立志,曾锐.微小RNA和长链非编码RNA作为心脏疾病生物标志物的研究进展[J].中国循环杂志,2017,32(11):1131-1133. 被引量:7
-
5何婧怡,胡春宏.替莫唑胺治疗胶质母细胞瘤耐药机制的研究进展[J].中国现代应用药学,2019,36(23):3001-3007. 被引量:8
-
6蔡国强,陈雪军,王峰.LncRNA GAS5通过AKT/mTOR通路对结肠癌SW480细胞增殖和凋亡的影响[J].热带医学杂志,2020,20(2):185-190. 被引量:8
-
7唐杰庆,秦龙梅,李洁.lncRNA THAP9-AS1靶向miR-577调控结直肠癌细胞的增殖、迁移和侵袭[J].热带医学杂志,2021,21(1):26-30. 被引量:3
-
8吴明娜,张贵海.免疫检查点抑制剂在胶质瘤治疗中的研究现状[J].热带医学杂志,2019,0(5):664-668. 被引量:4
二级引证文献2
-
1闫海成,苏乌云,李玉莲,都兰,陈秀兰,刘淑娟,王薇.miR-3941抑制securin的表达对神经胶质瘤细胞的影响[J].热带医学杂志,2022,22(11):1461-1466.
-
2张文青,何迎春(综述),王贤文(审校).长链非编码RNA Linc00467在肿瘤中的作用研究进展[J].疑难病杂志,2024,23(1):112-117.
-
1张道宝,张列,刘家刚,宋伟正,宋博,余水,毛庆.伽玛刀治疗对胶质母细胞瘤复发时间的影响[J].华西医学,2008,23(5):960-961.
-
2康彩梅,牛建清.胰岛素抵抗与子宫内膜癌相关性的研究进展[J].河北医药,2015,37(15):2352-2354. 被引量:1
-
3徐启英,李小平,魏丽惠.子宫内膜癌化疗进展[J].中国妇产科临床杂志,2011,12(4):311-313. 被引量:6
-
4FU Jun,LIU Zhi-gang,LIU Xiao-mei,CHEN Fu-rong,SHI Hong-liu,PANG Jesse Chung-sean,NG Ho-keung,CHEN Zhong-ping.Glioblastoma stem cells resistant to temozolomide-induced autophagy[J].Chinese Medical Journal,2009(11):1255-1259. 被引量:20
-
5孙红军,荔志云.Notchl通路介导胶质瘤干细胞耐药的研究进展[J].中华神经外科杂志,2016,32(11):1186-1188.
-
6易林华,傅相平,李安民,张志文,杜楠.造血干细胞支持下复发脑胶质母细胞瘤化疗的初步研究[J].中国微侵袭神经外科杂志,2003,8(12):543-544.
-
7浮姣,侯鹏,施秉银.甲状腺癌治疗进展[J].药品评价,2012(13):6-12. 被引量:8
-
8于宏.甲状腺癌的预防及外科治疗进展[J].保健医苑,2012(3):34-35.
-
9丁瑞(综述),王剑松(审校).雄激素非依赖性前列腺癌的治疗现状[J].医学新知,2013(1):56-59.
-
10吕蒙,仝林虎.胆囊癌的TNM分期与治疗[J].中国现代普通外科进展,2015,18(11):912-914. 被引量:1